Long noncoding RNA LINC-PINT inhibits non-small cell lung cancer progression through sponging miR-218-5p/PDCD4

10.21037/jtd.2018.05.75

10.3390/nu8120810

10.1051/bmdcn/2017070423

10.1016/S2095-4964(14)60034-0

10.1016/j.lungcan.2018.11.011

Criss SD, Mooradian MJ, Sheehan DF, et al. Cost-effectiveness and budgetary consequence analysis of Durvalumab consolidation therapy vs no consolidation therapy after chemoradiotherapy in stage III non-small cell lung cancer in the context of the US health care system. JAMA Oncol. 2018;5:.

10.1016/S2213-2600(18)30284-4

10.1159/000495935

10.1016/j.cell.2018.01.011

10.1007/s13277-015-4189-1

10.1002/cam4.1677

10.1038/s41419-018-0893-2

10.1080/15384101.2018.1496745

10.1016/j.prp.2018.04.014

10.1038/s41598-017-05856-2

10.1002/jcp.26590

Feng H, Zhang J, Shi Y, et al. Long noncoding RNA LINC-PINT is inhibited in gastric cancer and predicts poor survival. J Cell Biochem. 2018;:2119–2124.

10.1038/s41467-018-06862-2

10.18632/oncotarget.24401

10.18632/oncotarget.12365

10.1111/cpr.12515

10.1159/000493623

10.1159/000494868

10.1159/000480414

10.1016/j.ebiom.2018.10.004

10.1016/j.biopha.2018.06.073

10.1097/CAD.0000000000000650

Liu S, Duan W. Long noncoding RNA LINC00339 promotes laryngeal squamous cell carcinoma cell proliferation and invasion via sponging miR-145. J Cell Biochem. 2018;28:8272–8279.